The components of HMOX-1/CO pathway have been shown in hepatocellular carcinoma cells to confer their resistance to TGF-β-mediated growth inhibition by increasing Smad3 phosphorylation via the ERK1/2 pathway [67]. Here, MAPK3 is linked to hepatocellular carcinoma.